Welcome Mårten Winge!
May 04, 2022. We are happy to introduce our latest board member Mårten Winge. Mårten has an extensive executive management and advisory experience from life science startups and growth companies. Currently he is the CEO of Strike Pharma AB in Uppsala. Mårten has a broad international business network.Warm welcome Mårten as a valuable member of […]
Inossia awarded a Vinnova, Swelife and Medtech4Healths grant
2022-03-29 Inossia is very happy to announce that we have been awarded a Vinnova, Swelife and Medtech4Healths grant in the call “Samverkansprojekt för bättre hälsa”. From a total of 94 contributions, only 14 were selected. Inossia will together with our partners at Akademiska sjukhuset and Stockholm School of Economics, evaluate the clinical outcomes and establish a road-to-market […]
Welcoming Krankenhaus Mechernich
March 17, 2022. We are happy to welcome a new center – Krankenhaus Mechernich – who has now joined our multicenter randomized clinical trial of soft cement V-Flex with the aim of including 150 patients in Europe. Dr. Robert Pflugmacher is joining Dr. David Eschman – UMM Universitätsmedizin Mannheim, Dr. Raquel Gutiérrez-González – Hospital Universitario […]
Welcome Christina!
Our company is growing and we are happy to introduce our newest team member Christina Lidén as Inossia’s new Business Development Manager. Christina has extensive experience in customer relations, sales, marketing and project management, and has held leading positions in Sweden and international businesses, with a focus on the medical field. Warm welcome Christina!
Inossia at Eurospine 2021
October 6-8, 2021 – Inossia was present at the Eurospine meeting, which took place in Vienna, Austria. Inossia supported customer G21 in the exhibition of first bone adapted cement V-Flex, and networked with companies and clinicians working to improve the quality of life of patients suffering from spinal problems.
Inossia at Griboi 2021
September 8-10, 2021 – Inossia was present at the Interdisciplinary Research Conference for Injectable Osteoarticular Biomaterials (Griboi) – Sardinia Spine and Stroke 2021 joint meeting in Sardinia. For the first time, Inossia and partner company G21 showcased and demonstrated V-Flex – A flexible bone cement for percutaneous vertebral augmentation procedures. Inossia also had the opportunity to […]
Inossia’s QMS is now ISO 13485 certified
August 24, 2021 – Inossia receives ISO 13485 Quality Management System for Medical Devices certification. Certificate no. C002499 from RISE Research Institutes of Sweden AB. See the certificate
Inossia AB announces Enrollment of First Patient in European Multicenter Randomized Clinical Trial
On Friday the 12th of March, 2021 the first patient of the study was enrolled. The study is a multicenter, prospective, single-blind, randomized, controlled clinical investigation to document the safety and efficacy of the use of V-Flex, a bone cement with adapted stiffness containing Inossia® Cement Softener, in patients with vertebral compression fractures caused by […]
Inossia® presented during Republic of Korea state visit
Our CEO, Malin Nilsson, presented Inossia® to the Speaker of the National Assembly of Korea, H.E Mr Park Byeong-seug and His delegation at Uppsala castle. The visit was hosted by the Governor of the Uppsala province, Mr Göran Enander. Read the article on Uppsala Innovation Centre website.
Inossia® signs Global Distribution Agreement with G21 in Italy
This agreement will expand the market for G21 and at the same time we will have the possibility to create awareness of our coming product, the soft cement. We are very happy about this agreement and look forward to the launch of our soft cement.
